Jeffrey M Leiden - Net Worth and Insider Trading

Jeffrey M Leiden Net Worth

The estimated net worth of Jeffrey M Leiden is at least $54 Million dollars as of 2024-03-28. Jeffrey M Leiden is the President and COO of Abbott Laboratories and owns about 401,882 shares of Abbott Laboratories (ABT) stock worth over $46 Million. Jeffrey M Leiden is the Executive Chairman of Vertex Pharmaceuticals Inc and owns about 18,336 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $8 Million. Jeffrey M Leiden is also the Director of Quest Diagnostics Inc and owns about 6,000 shares of Quest Diagnostics Inc (DGX) stock worth over $796,740. Details can be seen in Jeffrey M Leiden's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey M Leiden has not made any transactions after 2024-02-15 and currently still holds the listed stock(s).

Transaction Summary of Jeffrey M Leiden

To

Jeffrey M Leiden Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey M Leiden owns 5 companies in total, including Vertex Pharmaceuticals Inc () , Quest Diagnostics Inc () , and Abbott Laboratories () among others .

Click here to see the complete history of Jeffrey M Leiden’s form 4 insider trades.

Insider Ownership Summary of Jeffrey M Leiden

Ticker Comapny Transaction Date Type of Owner
Vertex Pharmaceuticals Inc 2024-02-15 director
Quest Diagnostics Inc 2018-05-29 director
Abbott Laboratories 2006-02-17 director & President & COO
Revolution Healthcare Acquisition Corp 2021-03-17 director
Revolution Healthcare Acquisition Corp 2021-03-17 director

Jeffrey M Leiden Latest Holdings Summary

Jeffrey M Leiden currently owns a total of 3 stocks. Among these stocks, Jeffrey M Leiden owns 401,882 shares of Abbott Laboratories (ABT) as of February 17, 2006, with a value of $46 Million and a weighting of 84.32%. Jeffrey M Leiden owns 18,336 shares of Vertex Pharmaceuticals Inc (VRTX) as of February 15, 2024, with a value of $8 Million and a weighting of 14.21%. Jeffrey M Leiden also owns 6,000 shares of Quest Diagnostics Inc (DGX) as of May 29, 2018, with a value of $796,740 and a weighting of 1.48%.

Latest Holdings of Jeffrey M Leiden

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABT Abbott Laboratories 2006-02-17 401,882 113.28 45,525,193
VRTX Vertex Pharmaceuticals Inc 2024-02-15 18,336 418.38 7,671,416
DGX Quest Diagnostics Inc 2018-05-29 6,000 132.79 796,740

Holding Weightings of Jeffrey M Leiden


Jeffrey M Leiden Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey M Leiden has made a total of 0 transactions in Abbott Laboratories (ABT) over the past 5 years. The most-recent trade in Abbott Laboratories is the sale of 2,000 shares on February 17, 2006, which brought Jeffrey M Leiden around $88,820.

According to the SEC Form 4 filings, Jeffrey M Leiden has made a total of 24 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 0 buys and 24 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 9,011 shares on February 15, 2024, which brought Jeffrey M Leiden around $4 Million.

According to the SEC Form 4 filings, Jeffrey M Leiden has made a total of 0 transactions in Quest Diagnostics Inc (DGX) over the past 5 years. The most-recent trade in Quest Diagnostics Inc is the sale of 1,644 shares on May 29, 2018, which brought Jeffrey M Leiden around $173,623.

Insider Trading History of Jeffrey M Leiden

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey M Leiden Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey M Leiden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey M Leiden is -10.23%. GuruFocus also compares Jeffrey M Leiden's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey M Leiden within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey M Leiden's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey M Leiden

Average Relative Return

35.59%

Average relative return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -11.2 -10.23 -7.81 35.59 -2.06 27.31
Relative Return to S&P 500(%) -1.25 -3.54 -8.42 23.26 -9.04 17.18

Jeffrey M Leiden Ownership Network

Ownership Network List of Jeffrey M Leiden

No Data

Ownership Network Relation of Jeffrey M Leiden


Jeffrey M Leiden Owned Company Details

What does Vertex Pharmaceuticals Inc do?

Who are the key executives at Vertex Pharmaceuticals Inc?

Jeffrey M Leiden is the director of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP & Chief Technical Ops. Off. Atkinson Edward Morrow Iii , SVP & Chief Accounting Officer Kristen Ambrose , and EVP & Global Research and CSO David Altshuler .

Vertex Pharmaceuticals Inc () Insider Trades Summary

Over the past 18 months, Jeffrey M Leiden made 7 insider transaction in Vertex Pharmaceuticals Inc () with a net sale of 58,330. Other recent insider transactions involving Vertex Pharmaceuticals Inc () include a net sale of 32,309 shares made by David Altshuler , a net sale of 53,744 shares made by Stuart A Arbuckle , and a net sale of 23,021 shares made by Bastiano Sanna .

In summary, during the past 3 months, insiders sold 76,347 shares of Vertex Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 76,347 shares. During the past 18 months, 382,249 shares of Vertex Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 382,249 shares.

Vertex Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vertex Pharmaceuticals Inc Insider Transactions

No Available Data

Jeffrey M Leiden Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey M Leiden. You might contact Jeffrey M Leiden via mailing address: 15 N Beach Road, Hobe Sound Fl 33455.

Discussions on Jeffrey M Leiden

No discussions yet.